35 Kazia Theraputics Limited Annual Report 2022 2022 at a Glance Chairman’s Letter CEO’s Report Key Milestones Pipeline Review ESG Financial Reports Shareholding The number of shares in the company held during the financial year by each director and other members of Key Management Personnel of the consolidated entity, including their personally related parties, is set out below: Balance at the start of the year Purchased on market Disposed* (For KMP reporting purposes only) Exercise of options Balance at the end of the year Ordinary shares B Carmine 372,693 47,169 - - 419,862 S Coffey 434,265 50,000 - - 484,265 I Ross 1,000,001 75,000 - - 1,075,001 J Garner 430,000 70,000 - - 500,000 K Hill 295,000 - - 25,000 320,000 G Heaton 113,168 - (113,168) - - 2,645,127 242,169 (113,168) 25,000 2,799,128 * G Heaton still holds 113,168 shares. Disposal is for the purposes of KMP reporting only. Vested and exercisable Unvested Balance at the end of the year Options over ordinary shares - vested and unvested J Garner 1,850,000 2,650,000 4,500,000 K Hill 37,500 162,500 200,000 I Ross 300,000 100,000 400,000 B Carmine 300,000 100,000 400,000 S Coffey 300,000 100,000 400,000 J Friend - 800,000 800,000 K Krumeich - 800,000 800,000 2,787,500 4,712,500 7,500,000 Other transactions with key management personnel and their related parties There was no other transaction with KMP and their related parties. This concludes the remuneration report, which has been audited. Our Collaborators
RkJQdWJsaXNoZXIy MjE2NDg3